Shockwave therapy: the regenerative promise, graded

What it is, and what it is supposed to do

Low-intensity extracorporeal shockwave therapy (LiSWT) uses a handheld probe to deliver acoustic pressure pulses through the skin into the erectile chambers, at a small fraction of the energy used to shatter kidney stones. A typical protocol from the trials is six to twelve sessions over a few weeks, a few hundred to a few thousand pulses per session, applied along the shaft and at the crura where the chambers anchor to the pelvis. It does not hurt much; most men describe a tapping sensation.

The proposed mechanism comes from orthopedics and cardiology, where shockwave has a longer history. Mechanical stress on tissue triggers a repair response: release of growth factors, recruitment of progenitor cells, new capillary formation, and in animal models of diabetic and nerve-injured erectile tissue, regrowth of smooth muscle and nerve fibers. That is the regenerative claim, and in rats it is well supported. The question is what happens in a fifty-eight-year-old man with twenty years of endothelial wear, and that is where the trials come in.

What the trials found

The modern story starts in Haifa. A 2010 pilot was followed by the first randomized, double-blind, sham-controlled trial in 2012, and the numbers from it are the ones still quoted:

The difference is real and it is smaller than it first reads. The minimum change on that scale that a man can actually feel is about four points; the treatment-versus-sham gap here is under that. Later trials sharpened the picture:

• PDE5 non-responders (2016, 58 men, sham-controlled): after shockwave, 54% could achieve a penetration-hard erection on their pill again, versus none in the sham group. This is the strongest single result in the field: not a cure, but converting a man for whom tadalafil had stopped working back into one for whom it works.
• A second non-responder trial (2021, 76 men, electromagnetic device): 52% versus 28% with a functional erection at six months. Positive, modest, consistent with the first.
• Negative trials exist. A Scandinavian sham-controlled trial found no benefit, and a 2023 sham-controlled trial in moderate ED was likewise unconvincing. Publication bias is a live concern in a field where most trials are small and many are run by device makers or enthusiasts.
• Meta-analyses land where you would expect. The 2017 European Urology pooled analysis of 14 studies and 833 men found a mean IIEF gain of 2.0 points over control; a 2019 analysis of sham-controlled trials only, 873 men, found 4.0 points and a fourfold higher odds of reaching a usable erection hardness. Both note the benefit concentrates in mild to moderate vascular ED and thins out in severe disease and diabetes.

How long it lasts

The best durability data come from the same Haifa group following 156 treated men for two years. Roughly two-thirds responded initially. Of those responders, about half still had the benefit at two years. The split was not random: men with milder ED and no diabetes had about a three-in-four chance of holding their gains, while every diabetic man with severe ED at baseline had lost his. Read that as a selection rule. Shockwave appears to help tissue that still has something to work with, and to wash out where the disease has already won.

Retreatment after the effect fades has been reported, and clinics sell “maintenance” sessions on that basis, but there is no controlled evidence yet on whether a second course repeats the first.

Why the guidelines still say investigational

The American Urological Association guideline classifies low-intensity shockwave as investigational. The Sexual Medicine Society of North America, in a 2021 position statement covering shockwave, platelet-rich plasma, and stem cells together, found an absence of robust data and said these restorative therapies should be offered inside clinical trials, or with explicit informed consent that the evidence is preliminary. The European guideline is a shade warmer and allows it as an option in mild vascular ED. None of them recommend it as first-line, and none of them say it is a scam. The honest reading is: a real, small, selective effect that has not yet been pinned down well enough to standardize.

The standardization problem is concrete. Trials differ on energy density, pulse count, session number, spacing, treatment sites, and device type, and nobody knows which of those matter. That makes it impossible to say “shockwave works” the way one can say “tadalafil works,” because there is no single thing called shockwave being tested.

The device problem, and the clinic problem

This is the part to take into the consultation. The positive trials used focused shockwave units: electrohydraulic, electromagnetic, or piezoelectric generators that converge a true shockwave at a set depth in the tissue. A large share of what is sold in the US under names like GAINSWave and “acoustic wave therapy” is delivered with radial pressure wave devices, which use a pneumatic hammer to make a slower, unfocused pulse that dissipates at the surface. They are cheaper, they are cleared for musculoskeletal pain, and they are physically not the thing that was tested. There are small studies of radial devices for ED, and some are positive, but the evidence base above does not transfer to them automatically.

Then the money. A course in the US commonly runs $2,000 to $6,000, cash, because nothing investigational is covered. That price is set by what men will pay for the word “cure,” not by the cost of running a machine, and it is the reason the treatment is so heavily marketed. Franchise clinics, chiropractors, and med-spas offer it alongside IV drips and testosterone pellets; some pair it with a platelet-rich plasma injection as a package. None of that is illegal, and at these energies it is very unlikely to hurt you. The risk is the opportunity cost: a man who spends four thousand dollars on sessions has often skipped the workup that would have found the blood pressure, the glucose, or the low testosterone that was the actual problem, and that a ten-dollar generic would have treated in the meantime.

Questions that sort a serious provider from a franchise: Is the device focused or radial, and which model? What energy density and pulse count, and which published protocol is it based on? Is it a urologist or sexual-medicine physician supervising? Will you do a workup first, or have I already had one? What happens if it does not work at three months?

Who it might genuinely help

Take the evidence at face value and a candidate emerges:

• Mild to moderate vascular ED, diagnosed as such, with the cardiometabolic causes already being treated. This is where every meta-analysis puts the effect.
• A man whose pills have stopped working and who wants to try to get them working again before moving to injections. The non-responder trials are the strongest case for the treatment.
• A man who wants a drug-free option and understands the trade: a modest, uncertain, time-limited gain, with essentially no physical risk, at a price that is entirely his.
• Inside a clinical trial, which is where the guideline societies would prefer to see it, and where it is often free.

And where it has been tested and lost: after prostatectomy, where a randomized trial adding shockwave to early tadalafil found no difference; in severe diabetic ED, where the two-year data show it washing out; and for Peyronie's curvature, where a placebo-controlled trial found it relieved pain but did nothing to the bend.

The bottom line

Shockwave therapy is the first ED treatment built on the idea of repair, and the idea is not wrong: sham-controlled trials show a real, modest gain, concentrated in mild vascular disease, that lasts a year or two in about half the men who respond. It is also investigational, unstandardized, uncovered, and frequently sold with a different machine than the one that was studied. If you are the candidate the trials describe and you go in with the numbers above, it is a defensible experiment on yourself, with the workup done first and a urologist in the loop. If you are being sold a cure, the evidence for that does not exist yet. The frontier is real and it is worth watching; the trick is to arrive at it as the man the trials were about.

Common questions